U.S. Market for In-Vitro Diagnostics 2011

Sep 05, 2011, 04:59 ET from Reportlinker

NEW YORK, Sept. 5, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

U.S. Market for In-Vitro Diagnostics 2011

http://www.reportlinker.com/p0610526/US-Market-for-In-Vitro-Diagnostics-2011.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

By 2017, the U.S. in vitro diagnostic market is expected to approach $10 billion. The market segments covered in the U.S. Markets for In Vitro Diagnostics 2011 include:

- Immunochemistry,

- Immunochemistry Analyzer

- Immunology Diagnostic

- Chemistry Diagnostics

- Automated Urinalysis Instrument

- Molecular Diagnostics

- Molecular Diagnostics Reagent

- Molecular Diagnostics Instrument

- Hemostasis

- Hemostasis Analyzer

- Hemostasis Reagent

- Hematology

- Hematology Analyzer Market

- Hematology Reagent

- Blood Donor Screening

- Blood Screening Analyzer

- Blood Screening Assay Kit

- Point-of-Care Testing

- Blood Gas Testing

- Urinalysis Testing

- Blood Glucose Testing

In 2010, the U.S. in vitro diagnostics market experienced significant growth due to the introduction of new Food and Drug Administration (FDA) approved assays. That year, many technologies were well established and equipment markets were saturated. However, innovation, demand for testing and development of new assays will drive market growth.

Within the in vitro diagnostics market, companies such as Siemens, Roche Diagnostics, Abbott Diagnostics and Beckman Coulter lead the market, among many others. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2017, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios.

The executive summary of this report is also available for purchase.

TABLE OF CONTENTS

TABLE OF CONTENTS.I

LIST OF FIGURES.VI

LIST OF CHARTS..XI

EXECUTIVE SUMMARY 1

1.1 U.S.MARKET FOR IN VITRO DIAGNOSTICS 1

1.2 GROWTH TRENDS BY SEGMENT .. 2

1.3 IMMUNOCHEMISTRY MARKET.. 3

1.4MOLECULAR DIAGNOSTICS MARKET 4

1.5 BLOOD DONOR SCREENING MARKET 5

1.6 HEMOSTASIS MARKET.. 6

1.7 HEMATOLOGY MARKET .. 7

1.8 POINT-OF-CARE TESTING MARKET 8

1.9 COMPETITIVE ANALYSIS . 9

RESEARCH METHODOLOGY 10

2.1 RESEARCH SCOPE . 10

2.2 IDATA'S 9-STEP METHODOLOGY . 10

2.2.1 Step 1: Project Initiation & Team Selection 11

2.2.2 Step 2: Prepare Data Systems and Perform Secondary Research 12

2.2.3 Step 3: Preparation for Interviews & Questionnaire Design . 13

2.2.4 Step 4: Performing Primary Research 14

2.2.5 Step 5: Research Analysis: Establishing Baseline Estimates . 16

2.2.6 Step 6: Market Forecast and Analysis 16

2.2.7 Step 7: Identify Strategic Opportunities 18

2.2.8 Step 8: Final Review and Market Release 19

2.2.9 Step 9: Customer Feedback and Market Monitoring.. 20

U.S. MARKET FOR IN VITRO DIAGNOSTICS .. 21

3.1 INTRODUCTION .. 21

3.2MARKET OVERVIEW 22

3.3 TREND ANALYSIS BY SEGMENT 27

3.4MARKET DRIVERS AND LIMITERS 30

3.4.1 Market Drivers 30

3.4.2 Market Limiters.. 32

3.5 COMPETITIVE ANALYSIS .. 34

3.5.1 Herfindahl Index 44

3.6MERGERS AND ACQUISITIONS 46

IMMUNOCHEMISTRY MARKET. 47

4.1 INTRODUCTION .. 47

4.2MARKET OVERVIEW 49

4.3MARKET ANALYSIS AND FORECAST .. 54

4.3.1 Immunochemistry Analyzer Market . 56

4.3.2 Immunoassay Market.. 59

4.3.2.1 Immunoassay Analyzer Market..61

4.3.2.2 Immunoassay Reagent Market64

4.3.3 Clinical Chemistry Market 78

4.3.3.1 Clinical Chemistry Analyzer Market ..80

4.3.3.1.1 High-Volume Clinical Chemistry Analyzer Market..83

4.3.3.1.2 Medium-Volume Clinical Chemistry Analyzer Market86

4.3.3.1.3 Low-Volume Clinical Chemistry Analyzer Market 89

4.3.3.2 Clinical Chemistry Reagent Market 92

4.3.4 Automated Urinalysis Analyzer Market.. 103

4.4MARKET DRIVERS AND LIMITERS . 106

4.4.1 Market Drivers. 106

4.4.2 Market Limiters 107

4.5 COMPETITIVE ANALYSIS 108

MOLECULAR DIAGNOSTICS MARKET. 113

5.1 INTRODUCTION 113

5.2MARKET OVERVIEW. 115

5.3MARKET ANALYSIS AND FORECAST 120

5.3.1 Molecular Diagnostics Instrument Market 122

5.3.2 Molecular Diagnostics Assay Market.. 125

5.3.2.1 Infectious Disease Assay Market 128

5.3.2.1.1 Blood-Borne Virus Assay Market 131

5.3.2.1.2 Women's Health Assay Market.140

5.3.2.1.3 MRSA and CMV Assay Market.149

5.3.2.2 Genetic Diagnostics Assay Market156

5.3.2.3 Oncology Assay Market..162

5.4MARKET DRIVERS AND LIMITERS . 171

5.4.1 Market Drivers. 171

5.4.2 Market Limiters 171

5.5 COMPETITIVE ANALYSIS 173

BLOOD DONOR SCREENING MARKET . 180

6.1 INTRODUCTION 180

6.2MARKET OVERVIEW. 183

6.3MARKET ANALYSIS AND FORECAST 188

6.3.1.1 Blood Donor Screening Analyzer Market..190

6.3.1.2 Blood Donor Screening Assay Market.193

6.4MARKET DRIVERS AND LIMITERS . 204

6.4.1 Market Drivers. 204

6.4.2 Market Limiters 204

6.5 COMPETITIVE ANALYSIS 206

HEMOSTASIS MARKET 209

7.1 INTRODUCTION 209

7.2MARKET OVERVIEW. 212

7.3MARKET ANALYSIS AND FORECAST 217

7.3.1.1 Hemostasis Analyzer Market 219

7.3.1.2 Hemostasis Reagent Market .222

7.4MARKET DRIVERS AND LIMITERS . 225

7.4.1 Market Drivers. 225

7.4.2 Market Limiters 226

7.5 COMPETITIVE ANALYSIS 227

HEMATOLOGY MARKET .. 230

8.1 INTRODUCTION 230

8.2MARKET OVERVIEW. 231

8.3MARKET FORECAST AND ANALYSIS 236

8.3.1 Hematology Analyzer Market .. 238

8.3.1.1 High-End Analyzer Market241

8.3.1.2 Low-End Analyzer Market.244

8.3.2 Hematology Reagent Market 247

8.4MARKET DRIVERS AND LIMITERS . 250

8.4.1 Market Drivers. 250

8.4.2 Market Limiters 250

8.5 COMPETITIVE ANALYSIS 252

POINT-OF-CARE TESTING MARKET .. 256

9.1 INTRODUCTION 256

9.2MARKET OVERVIEW. 259

9.3MARKET ANALYSIS AND FORECAST 265

9.3.1 Clinical Chemistry Market. 267

9.3.1.1 Clinical Chemistry Analyzer Market 269

9.3.1.2 Clinical Chemistry Reagent Market .272

9.3.2 Blood Gas Testing Market . 275

9.3.2.1 Blood Gas Analyzer Market..277

9.3.2.1.1 Handheld Blood Gas Analyzer Market .280

9.3.2.1.2 Decentralized Blood Gas Analyzer Market 283

9.3.2.2 Blood Gas Reagent Market286

9.3.3 Point-of-Care Urinalysis Market 295

9.3.3.1 Urinalysis Analyzer Market..297

9.3.3.2 Urinalysis Test Strip Market.300

9.3.4 Point-of-Care Blood Glucose Testing Market . 303

9.3.4.1 POC Blood Glucose Analyzer Market .305

9.3.4.2 POC Blood Glucose Test Strip Market308

9.4MARKET DRIVERS AND LIMITERS . 311

9.4.1 Market Drivers. 311

9.4.2 Market Limiters 312

9.5 COMPETITIVE ANALYSIS 314

ABBREVIATIONS 320

APPENDIX: MARKET BREAKDOWN BY TESTING SETTING . 322

LIST OF FIGURES

EXECUTIVE SUMMARY 1

RESEARCH METHODOLOGY.. 10

U.S. MARKET FOR IN VITRO DIAGNOSTICS 21

Figure 3-1: Total In Vitro Diagnostics Market by Segment, U.S., 2007 – 2017

(US$M) 23

Figure 3-2: Growth Rates by Segment, In Vitro Diagnostics Market, U.S.,

2007 – 2017 28

Figure 3-3: Market Drivers and Limiters, In Vitro Diagnostics Market, 2010. 33

Figure 3-4: Leading Competitors, In Vitro Diagnostics Market, 2010

(Part 1 of 2) 41

Figure 3-5: Leading Competitors, In Vitro Diagnostics Market, 2010

(Part 2 of 2) 42

Figure 3-6: H-Index, In Vitro Diagnostics Market, U.S., 2010.. 44

IMMUNOCHEMISTRY MARKET 47

Figure 4-1: Total Immunochemistry Market by Segment, U.S., 2007 – 2017

(US$M) 50

Figure 4-2: Total Immunochemistry Market, U.S., 2007 – 2017 54

Figure 4-3: Immunochemistry Analyzer Market, U.S., 2007 – 2017 57

Figure 4-4: Total Immunoassay Market, U.S., 2007 – 2017 59

Figure 4-5: Immunoassay Analyzer Market, U.S., 2007 – 2017 62

Figure 4-6: Immunoassay Market Test Groups . 65

Figure 4-7: Total Immunoassay Reagent Market, U.S., 2007 – 2017 .. 66

Figure 4-8: Immunoassay Tests Sold by Segment, U.S., 2007 – 2017 67

Figure 4-9: Immunoassay Reagent ASP by Segment, U.S., 2007 – 2017 (US$) . 68

Figure 4-10: Immunoassay Reagent Market by Segment, U.S., 2007 – 2017

(US$M) 69

Figure 4-11: Total Clinical Chemistry Market, U.S., 2007 – 2017 .. 78

Figure 4-12: Total Clinical Chemistry Analyzer Market, U.S., 2007 – 2017 81

Figure 4-13: High-Volume Clinical Chemistry Analyzer Market, U.S., 2007 – 2017

84

Figure 4-14: Medium-Volume Clinical Chemistry Analyzer Market, U.S.,

2007 – 2017 87

Figure 4-15: Low-Volume Clinical Chemistry Analyzer Market, U.S.,

2007 – 2017 90

Figure 4-16: Total Clinical Chemistry Reagent Market, U.S., 2007 – 2017 . 93

Figure 4-17: Clinical Chemistry Tests Sold by Segment, U.S., 2007 – 2017 94

Figure 4-18: Clinical Chemistry Reagent ASP by Segment, U.S., 2007 – 2017.. 95

Figure 4-19: Clinical Chemistry Reagent Market by Segment, U.S., 2007 – 2017

(US$M) 96

Figure 4-20: Automated Urinalysis Instrument Market, U.S., 2007 – 2017 104

Figure 4-21: Market Drivers and Limiters, Immunochemistry Market, 2010. 107

Figure 4-22: Leading Competitors, Immunochemistry Market, 2010 111

MOLECULAR DIAGNOSTICS MARKET.. 113

Figure 5-1: Total Molecular Diagnostics Market by Segment, U.S., 2007 – 2017

(US$M) . 116

Figure 5-2: Total Molecular Diagnostics Market, U.S., 2007 – 2017 120

Figure 5-3: Molecular Diagnostics Instrument Market, U.S., 2007 – 2017 123

Figure 5-4: Total Molecular Diagnostics Assay Market, U.S., 2007 – 2017.. 126

Figure 5-5: Total Infectious Disease Assay Market, U.S., 2007 – 2017 .. 129

Figure 5-6: Total Blood-Borne Virus Assay Market, U.S., 2007 – 2017 . 132

Figure 5-7: Blood-Borne Virus Tests Sold by Segment, U.S., 2007 – 2017 .. 133

Figure 5-8: Blood-Borne Virus Assay ASP by Segment, U.S., 2007 – 2017

(US$) . 134

Figure 5-9: Blood-Borne Virus Assay Market by Segment, U.S., 2007 – 2017

(US$M) . 135

Figure 5-10: Total Women's Health Assay Market, U.S., 2007 – 2017 141

Figure 5-11: Total Women's Health Tests Sold by Segment, U.S., 2007 – 2017 . 142

Figure 5-12: Total Women's Health Assay ASP by Segment, U.S., 2007 – 2017

(US$) . 143

Figure 5-13: Total Women's Health Assay Market by Segment, U.S., 2007 – 2017

(US$M) . 144

Figure 5-14: Total MRSA and CMV Assay Market, U.S., 2007 – 2017 .. 150

Figure 5-15: Total MRSA and CMV Tests Sold by Segment, U.S.,

2007 – 2017. 151

Figure 5-16: Total MRSA and CMV Assay ASP by Segment, U.S., 2007 – 2017

(US$) . 151

Figure 5-17: Total MRSA and CMV Market by Segment, U.S., 2007 – 2017

(US$M) . 152

Figure 5-18: Total Genetic Diagnostics Assay Market, U.S., 2007 – 2017. 157

Figure 5-19: Total Genetic Diagnostics Tests Sold by Segment, U.S.,

2007 – 2017. 157

Figure 5-20: Total Genetic Diagnostics Assay ASP by Segment, U.S.,

2007 – 2017. 158

Figure 5-21: Total Genetic Diagnostics Assay Market by Segment, U.S.,

2007 – 2017 (US$M) .. 158

Figure 5-22: Total Oncology Assay Market, U.S., 2007 – 2017 . 163

Figure 5-23: Total Oncology Tests Sold by Segment, U.S., 2007 – 2017 164

Figure 5-24: Total Oncology Assay ASP by Segment, U.S., 2007 – 2017

(US$) . 165

Figure 5-25: Total Oncology Assay Market by Segment, U.S., 2007 – 2017

(US$M) . 166

Figure 5-26: Market Drivers and Limiters, Molecular Diagnostics Market,

2010 172

Figure 5-27: Leading Competitors, Molecular Diagnostics Market, 2010 .. 178

BLOOD DONOR SCREENING MARKET.. 180

Figure 6-1: Total Blood Donor Screening Market by Segment, U.S., 2007 – 2017

(US$M) . 184

Figure 6-2: Total Blood Donor Screening Market, U.S., 2007 – 2017 . 188

Figure 6-3: Blood Donor Screening Analyzer Market, U.S., 2007 – 2017.. 191

Figure 6-4: Total Blood Donor Screening Assay Market, U.S., 2007 – 2017 194

Figure 6-5: Blood Donor Screening Units Sold by Segment, U.S., 2007 – 2017 . 195

Figure 6-6: Blood Donor Screening Assay ASP by Segment, U.S., 2007 – 2017

(US$) . 196

Figure 6-7: Blood Donor Screening Assay Market by Segment, U.S., 2007 – 2017

(US$M) . 197

Figure 6-8: Market Drivers and Limiters, Blood Donor Screening Market,

2010 205

Figure 6-9: Leading Competitors, Blood Donor Screening Market, 2010 .. 207

HEMOSTASIS MARKET 209

Figure 7-1: Hemophilia Classification .. 210

Figure 7-2: Total Hemostasis Market by Segment, U.S., 2007 – 2017 (US$M) 213

Figure 7-3: Total Hemostasis Market, U.S., 2007 – 2017.. 217

Figure 7-4: Hemostasis Analyzer Market, U.S., 2007 – 2017 .. 220

Figure 7-5: Hemostasis Reagent Market, U.S., 2007 – 2017 223

Figure 7-6: Market Drivers and Limiters, Hemostasis Market, 2010 226

Figure 7-7: Leading Competitors, Hemostasis Market, 2010 228

HEMATOLOGY MARKET 230

Figure 8-1: Total Hematology Market by Segment, U.S., 2007 – 2017 (US$M).. 232

Figure 8-2: Total Hematology Market, U.S., 2007 – 2017 236

Figure 8-3: Total Hematology Analyzer Market, U.S., 2007 – 2017 . 239

Figure 8-4: High-End Analyzer Market, U.S., 2007 – 2017 . 242

Figure 8-5: Low-End Analyzer Market, U.S., 2007 – 2017 .. 245

Figure 8-6: Hematology Reagent Market, U.S., 2007 – 2017 .. 248

Figure 8-7: Market Drivers and Limiters, Hematology Market, 2010 .. 251

Figure 8-8: Leading Competitors, Hematology Market, 2010.. 254

POINT-OF-CARE TESTING MARKET 256

Figure 9-1: Total POC Testing Market by Segment, U.S., 2007 – 2017

(US$M) . 260

Figure 9-2: Total POC Testing Market Segments by Percentage, U.S.,

2007 – 2017. 261

Figure 9-3: Total POC Testing Market by Product Type, U.S., 2007 – 2017. 261

Figure 9-4: Total POC Testing Market, U.S., 2007 – 2017 .. 265

Figure 9-5: Clinical Chemistry Market, U.S., 2007 – 2017 .. 267

Figure 9-6: Clinical Chemistry Analyzer Market, U.S., 2007 – 2017 270

Figure 9-7: Clinical Chemistry Reagent Market, U.S., 2007 – 2017 . 273

Figure 9-8: Blood Gas Testing Market, U.S., 2007 – 2017 275

Figure 9-9: Total Blood Gas Analyzer Market, U.S., 2007 – 2017 278

Figure 9-10: Handheld Blood Gas Analyzer Market, U.S., 2007 – 2017 . 281

Figure 9-11: Decentralized Blood Gas Analyzer Market, U.S., 2007 – 2017. 284

Figure 9-12: Total Blood Gas Reagent Market, U.S., 2007 – 2017 287

Figure 9-13: Blood Gas Reagent Units Sold by Packaging Type Market, U.S.,

2007 – 2017. 288

Figure 9-14: Blood Gas Reagent ASP by Packaging Type Market, U.S.,

2007 – 2017 (US$) 289

Figure 9-15: Blood Gas Reagent Market by Packaging Type, U.S., 2007 – 2017

(US$M) . 290

Figure 9-16: POC Urinalysis Market, U.S., 2007 – 2017 .. 295

Figure 9-17: Urinalysis Analyzer Market, U.S., 2007 – 2017.. 298

Figure 9-18: POC Urinalysis Test Strip Market, U.S., 2007 – 2017 . 301

Figure 9-19: POC Blood Glucose Testing Market, U.S., 2007 – 2017 . 303

Figure 9-20: POC Blood Glucose Analyzer Market, U.S., 2007 – 2017 .. 306

Figure 9-21: POC Blood Glucose Test Strip Market, U.S., 2007 – 2017. 309

Figure 9-22: Market Drivers and Limiters, Point-of-Care Testing Market,

2010 313

Figure 9-23: Leading Competitors, Point-of-Care Testing Market, 2010 318

ABBREVIATIONS 320

APPENDIX: MARKET BREAKDOWN BY TESTING SETTING 322

Figure 11-1: Market Proportion by Testing Setting, 2010 . 322

LIST OF CHARTS

EXECUTIVE SUMMARY 1

Chart 1-1: Total U.S. In Vitro Diagnostics Market by Segment, U.S., 2010 .. 1

Chart 1-2: Growth Rates by Segment, In Vitro Diagnostics Market, U.S.,

2007 – 2017.. 2

Chart 1-3: Immunochemistry Assay Volume Growth Rates by Segment, U.S.,

2007 – 2017.. 3

Chart 1-4: Infectious Disease Assay Market by Segment, U.S., 2010 4

Chart 1-5: Blood Donor Screening Market, U.S., 2010 .. 5

Chart 1-6: Hemostasis Market by Segment, U.S., 2010 6

Chart 1-7: Hematology Market by Segment, U.S., 2007 – 2017 .. 7

Chart 1-8: POC Testing Market, U.S., 2007 – 2017 .. 8

Chart 1-9: Leading Competitors, In Vitro Diagnostics Market, U.S., 2010 . 9

RESEARCH METHODOLOGY.. 10

U.S. MARKET FOR IN VITRO DIAGNOSTICS 21

Chart 3-1: Total In Vitro Diagnostics Market by Segment, U.S., 2007 – 2017 24

Chart 3-2: Total In Vitro Diagnostics Market by Segment, U.S., 2010 .. 25

Chart 3-3: Total In Vitro Diagnostics Market by Segment, U.S., 2017 .. 26

Chart 3-4: Growth Rates by Segment, In Vitro Diagnostics Market, U.S.,

2007 – 2017 29

Chart 3-5: Leading Competitors, In Vitro Diagnostics Market, 2010.. 43

Chart 3-6: H-Index, In Vitro Diagnostics Market, U.S., 2010 45

IMMUNOCHEMISTRY MARKET 47

Chart 4-1: Total Immunochemistry Market by Segment, U.S., 2007 – 2017 51

Chart 4-2: Total Immunochemistry Market by Segment, U.S., 2010 52

Chart 4-3: Total Immunochemistry Market by Segment, U.S., 2017 53

Chart 4-4: Total Immunochemistry Market, U.S., 2007 – 2017 . 55

Chart 4-5: Immunochemistry Analyzer Market, U.S., 2007 – 2017 . 58

Chart 4-6: Total Immunoassay Market, U.S., 2007 – 2017.. 60

Chart 4-7: Immunoassay Analyzer Market, U.S., 2007 – 2017 .. 63

Chart 4-8: Total Immunoassay Reagent Market, U.S., 2007 – 2017. 70

Chart 4-9: Cardiovascular Reagent Market, U.S., 2007 – 2017 . 71

Chart 4-10: Cancer Reagent Market, U.S., 2007 – 2017 72

Chart 4-11: Infectious Disease Reagent Market, U.S., 2007 – 2017 73

Chart 4-12: Metabolic Reagent Market, U.S., 2007 – 2017 . 74

Chart 4-13: Endocrine Reagent Market, U.S., 2007 – 2017 . 75

Chart 4-14: Reproductive and Fertility Reagent Market, U.S., 2007 – 2017 76

Chart 4-15: Autoimmune Reagent Market, U.S., 2007 – 2017 77

Chart 4-16: Total Clinical Chemistry Market, U.S., 2007 – 2017 . 79

Chart 4-17: Total Clinical Chemistry Analyzer Market, U.S., 2007 – 2017 . 82

Chart 4-18: High-Volume Clinical Chemistry Analyzer Market, U.S.,

2007 – 2017 85

Chart 4-19: Medium-Volume Clinical Chemistry Analyzer Market, U.S.,

2007 – 2017 88

Chart 4-20: Low-Volume Clinical Chemistry Analyzer Market, U.S.,

2007 – 2017 91

Chart 4-21: Total Clinical Chemistry Reagent Market, U.S., 2007 – 2017 97

Chart 4-22: General Chemistry Reagent Market, U.S., 2007 – 2017 98

Chart 4-23: Specific Protein Reagent Market, U.S., 2007 – 2017 . 99

Chart 4-24: Therapeutic Drug Monitoring Reagent Market, U.S., 2007 – 2017 100

Chart 4-25: Drugs of Abuse Reagent Market, U.S., 2007 – 2017 .. 101

Chart 4-26: Special Chemistry Reagent Market, U.S., 2007 – 2017.. 102

Chart 4-27: Automated Urinalysis Instrument Market, U.S., 2007 – 2017 . 105

Chart 4-28: Leading Competitors, Immunochemistry Market, 2010 . 112

MOLECULAR DIAGNOSTICS MARKET.. 113

Chart 5-1: Total Molecular Diagnostics Market by Segment, U.S.,

2007 – 2017. 117

Chart 5-2: Total Molecular Diagnostics Market by Segment, U.S., 2010 118

Chart 5-3: Total Molecular Diagnostics Market by Segment, U.S., 2017 119

Chart 5-4: Total Molecular Diagnostics Market, U.S., 2007 – 2017 . 121

Chart 5-5: Molecular Diagnostics Instrument Market, U.S., 2007 – 2017 .. 124

Chart 5-6: Total Molecular Diagnostics Assay Market, U.S., 2007 – 2017 127

Chart 5-7: Total Infectious Disease Assay Market, U.S., 2007 – 2017 130

Chart 5-8: Total Blood-Borne Virus Assay Market, U.S., 2007 – 2017 .. 136

Chart 5-9: HIV Assay Market, U.S., 2007 – 2017. 137

Chart 5-10: HCV Assay Market, U.S., 2007 – 2017. 138

Chart 5-11: HBV Assay Market, U.S., 2007 – 2017. 139

Chart 5-12: Total Women's Health Assay Market, U.S., 2007 – 2017 . 145

Chart 5-13: HPV Assay Market, U.S., 2007 – 2017 . 146

Chart 5-14: HSV Assay Market, U.S., 2007 – 2017 . 147

Chart 5-15: CT/GC Assay Market, U.S., 2007 – 2017. 148

Chart 5-16: Total MRSA and CMV Assay Market, U.S., 2007 – 2017. 153

Chart 5-17: MRSA Assay Market, U.S., 2007 – 2017 . 154

Chart 5-18: CMV Assay Market, U.S., 2007 – 2017 155

Chart 5-19: Total Genetic Diagnostics Assay Market, U.S., 2007 – 2017 .. 159

Chart 5-20: CF Assay Market, U.S., 2007 – 2017 . 160

Chart 5-21: Inherited Thrombophilia Assay Market, U.S., 2007 – 2017 . 161

Chart 5-22: Total Oncology Assay Market, U.S., 2007 – 2017 167

Chart 5-23: Breast Cancer Assay Market, U.S., 2007 – 2017 .. 168

Chart 5-24: Colorectal Cancer Assay Market, U.S., 2007 – 2017 .. 169

Chart 5-25: Prostate Cancer Assay Market, U.S., 2007 – 2017 170

Chart 5-26: Leading Competitors, Molecular Diagnostics Market, 2010. 179

BLOOD DONOR SCREENING MARKET.. 180

Chart 6-1: Total Blood Donor Screening Market by Segment, U.S.,

2007 – 2017. 185

Chart 6-2: Total Blood Donor Screening Market by Segment, U.S., 2010 . 186

Chart 6-3: Total Blood Donor Screening Market by Segment, U.S., 2017 . 187

Chart 6-4: Total Blood Donor Screening Market, U.S., 2007 – 2017 189

Chart 6-5: Blood Donor Screening Analyzer Market, U.S., 2007 – 2017 192

Chart 6-6: Blood Donor Screening Assay Market, U.S., 2007 – 2017.. 198

Chart 6-7: Combined Assay Market, U.S., 2007 – 2017. 199

Chart 6-8: WNV Assay Market, U.S., 2007 – 2017.. 200

Chart 6-9: HIV Assay Market, U.S., 2007 – 2017. 201

Chart 6-10: HCV Assay Market, U.S., 2007 – 2017. 202

Chart 6-11: HBV Assay Market, U.S., 2007 – 2017. 203

Chart 6-12: Leading Competitors, Blood Donor Screening Reagent Market, U.S.,

2007 – 2017. 208

HEMOSTASIS MARKET 209

Chart 7-1: Total Hemostasis Market by Segment, U.S., 2007 – 2017 .. 214

Chart 7-2: Total Hemostasis Market by Segment, U.S., 2010.. 215

Chart 7-3: Total Hemostasis Market by Segment, U.S., 2017.. 216

Chart 7-4: Total Hemostasis Market, U.S., 2007 – 2017 218

Chart 7-5: Hemostasis Analyzer Market, U.S., 2007 – 2017 221

Chart 7-6: Hemostasis Reagent Market, U.S., 2007 – 2017 .. 224

Chart 7-7: Leading Competitors, Hemostasis Market, 2010 . 229

HEMATOLOGY MARKET 230

Chart 8-1: Total Hematology Market by Segment, U.S., 2007 – 2017 . 233

Chart 8-2: Total Hematology Market by Segment, U.S., 2010. 234

Chart 8-3: Total Hematology Market by Segment, U.S., 2017. 235

Chart 8-4: Total Hematology Market, U.S., 2007 – 2017 .. 237

Chart 8-5: Total Hematology Analyzer Market, U.S., 2007 – 2017 .. 240

Chart 8-6: High-End Analyzer Market, U.S., 2007 – 2017 243

Chart 8-7: Low-End Analyzer Market, U.S., 2007 – 2017. 246

Chart 8-8: Hematology Reagent Market, U.S., 2007 – 2017. 249

Chart 8-9: Leading Competitors, Hematology Market, 2010 255

POINT-OF-CARE TESTING MARKET 256

Chart 9-1: Total POC Testing Market by Segment, U.S., 2007 – 2017 262

Chart 9-2: Total POC Testing Market by Segment, U.S., 2010 263

Chart 9-3: Total POC Testing Market by Segment, U.S., 2017 264

Chart 9-4: Total POC Testing Market, U.S., 2007 – 2017 . 266

Chart 9-5: Total Clinical Chemistry Market, U.S., 2007 – 2017. 268

Chart 9-6: Clinical Chemistry Analyzer Market, U.S., 2007 – 2017 . 271

Chart 9-7: Clinical Chemistry Reagent Market, U.S., 2007 – 2017 .. 274

Chart 9-8: Blood Gas Testing Market, U.S., 2007 – 2017 . 276

Chart 9-9: Total Blood Gas Analyzer Market, U.S., 2007 – 2017.. 279

Chart 9-10: Handheld Blood Gas Analyzer Market, U.S., 2007 – 2017 .. 282

Chart 9-11: Decentralized Blood Gas Analyzer Market, U.S., 2007 – 2017 .. 285

Chart 9-12: Total Blood Gas Reagent Market, U.S., 2007 – 2017 . 291

Chart 9-13: Single-Use Cartridge Market, U.S., 2007 – 2017.. 292

Chart 9-14: Multi-Use Cartridge Market, U.S., 2007 – 2017 293

Chart 9-15: Other Reagent Market, U.S., 2007 – 2017 294

Chart 9-16: POC Urinalysis Market, U.S., 2007 – 2017 . 296

Chart 9-17: Urinalysis Analyzer Market, U.S., 2007 – 2017 299

Chart 9-18: POC Urinalysis Test Strip Market, U.S., 2007 – 2017 302

Chart 9-19: POC Blood Glucose Testing Market, U.S., 2007 – 2017 304

Chart 9-20: POC Blood Glucose Analyzer Market, U.S., 2007 – 2017 307

Chart 9-21: POC Blood Glucose Test Strip Market, U.S., 2007 – 2017 .. 310

Chart 9-22: Leading Competitors, Point-of-Care Testing Market, 2010.. 319

ABBREVIATIONS 320

APPENDIX: MARKET BREAKDOWN BY TESTING SETTING 322

To order this report:

In Vitro Diagnostic Industry: U.S. Market for In-Vitro Diagnostics 2011

In Vitro Diagnostic Business News

More  Market Research Report

Check our  Industry Analysis and Insights

Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker



RELATED LINKS

http://www.reportlinker.com